Categories: CancerNews

Erasca to Present at the Bank of America Health Care Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Bank of America Health Care Conference being held at the Encore Hotel in Las Vegas, Nevada. Management will present on Wednesday, May 15, 2024 at 4:20 pm Pacific Time and will also participate in one-on-one investor meetings.

A live audio webcast of the event will be available online at Erasca.com/events. An archived replay of the event will be available for 30 days following the webcast at Erasca.com/events.

About Erasca 
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of cancer. We have assembled one of the deepest RAS/MAPK pathway-focused pipelines in the industry. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.

Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com

Source: Erasca, Inc.

Staff

Recent Posts

Philips Future Health Index 2025 Report Highlights Significant Trust Gap in Healthcare AI Between Clinicians and Patients

AI in healthcare can address some of healthcare’s most pressing challenges, but trust barriers threaten…

7 minutes ago

New DiMe Seal Sets Benchmarks for Digital Health Products

Digital Medicine Society (DiMe) and Elevance Health collaborate to evaluate and elevate digital health software…

11 minutes ago

Novo Holdings appoints four new members to its Board of Directors further strengthening global perspectives and strategic capabilities

COPENHAGEN, Denmark, May 15, 2025 /PRNewswire/ -- Novo Holdings is pleased to announce the appointments…

11 minutes ago

Guelph General Hospital adds digital pathology to cloud service from Sectra–enables integrated diagnostics for improved patient care

LINKÖPING, Sweden and MISSISSAUGA, ON, May 15, 2025 /PRNewswire/ -- International medical imaging IT and…

11 minutes ago

Omnicell Announces New Products for Perioperative and Clinic Settings

RFID-Enabled Dispensing and Intelligent Inventory Management Software Aim to Unlock Greater Inventory Accuracy and Streamline…

12 hours ago

MARPAI REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

Marpai's turnaround momentum is building TAMPA, Fla., May 14, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or…

12 hours ago